Influenza vaccine coverage remains below the WHO-recommended threshold for risk groups in most EU/EEA countries, while COVID-19 vaccine coverage is declining across most countries.

The purpose of this study was to provide evidence on how to help public health laboratories be better prepared and more resilient to future public

A study published today shows how public health laboratories can become more resilient against future respiratory infectious diseases. The findings call for sustained capacity, better

A new modelling study from RespiCompass, the European respiratory disease modelling hub coordinated by ECDC, indicates that influenza and COVID-19 vaccination programmes markedly reduced hospitalisations

Respiratory viruses are on the rise across the EU/EEA: influenza activity is increasing rapidly and circulating widely, RSV is slowly increasing, while SARS-CoV-2 circulation continues

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 December 2025 and includes updates on respiratory virus epidemiology in the

This protocol describes the methods to estimate the Coronavirus disease 2019 (COVID-19) XBB.1.5. monovalent-adapted VE in immunocompromised persons (ICP), against COVID-19 hospitalisations and deaths.

SARS-CoV-2 and influenza viruses are significant public health threats with varying impacts on global health. SARS-CoV-2, the virus behind the COVID-19 pandemic, exhibits high transmissibility

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22 – 28 November 2025 and includes updates on respiratory virus epidemiology

Respiratory viruses are on the rise across the EU/EEA: influenza activity is increasing rapidly and circulating widely, RSV is slowly increasing, while SARS-CoV-2 circulation continues

Influenza detections are now increasing rapidly and earlier than usual. RSV circulation remains low, but is slowly starting to increase. SARS-CoV-2 circulation continues to decrease.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22 – 28 November 2025 and includes updates on respiratory virus epidemiology